Schedule 13G ownership disclosure

Kymera Therapeutics Inc

Security class unavailable · CUSIP: 501575104

Event date: 2022-06-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,224,686
Percent of class
10.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-22-002369
Form type
SC 13G/A
Filer
Kymera Therapeutics, Inc.
CIK
CIK 1815442
Filed
Jul 11, 2022
Reporting period
Jun 30, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub